Patient Pathfinder: Clinical Trials
Clinical Trials for Prostate Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 811 active Prostate Cancer trials
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Study Type: Interventional Phase 1
PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer
Study Type: Interventional Phase 4
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
Study Type: Interventional Phase 2
Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician’s Choice New Hormonal Agents
Study Type: Interventional Phase 3
A Study of Copanlisib in Combination With Degarelix in People With Prostate Cancer
Study Type: Interventional Phase 1
DeADT – Living Well With Prostate Cancer
Study Type: Interventional
A Study of MK-5684 Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Study Type: Interventional Phase 3
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Study Type: Interventional Phase 3
There are 811 active Prostate Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now